drugset / Trial / NCT03313726
The Effect of ADT on PSMA-PET.
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
Phase A: To describe and to determine the maximum standardised uptake values (SUV) in prostate specific membrane antigen positron emission tomography (PSMA-PET) before ADT and 7, 14 and 28 days after ADT. Phase B: To validate phase A results by comparing the PSMA-PET findings to histopathological analysis of regional lymph nodes acquired from radical prostatectomy specimens. PSMA-PET is done before ADT and at maximum SUV defined by the phase A.
Timeline
- Start
- 2017-09-20
- Primary completion
- 2018-09-30
- Completion
- 2018-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Degarelix | Other / unclassified | — | — |